Pharmaceutical Science
A section of Life (ISSN 2075-1729).
Section Information
This section of the journal Life aims to rapidly publish contributions related to pharmaceutical science. We encourage the submission of manuscripts that report significant advances in those fields. Topics include, but are not limited to, the following:
- pharmaceutical technology, pharmaceutics, novel drug delivery, biopharmaceutics, pharmacokinetics
- basic and clinical pharmacology, toxicology
- medicinal chemistry, computational chemistry and molecular drug design, pharmaceutical and biomedicinal analysis
- pharmacogenetics, pharmacogenomics
- epigenetic drugs, pharmacoepigenetics
- biotechnological products
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Pharmaceutical Biotechnology (Deadline: 9 August 2022)
- New Trends in Pharmaceutical Science (Deadline: 26 August 2022)
- Natural Products and Their Applications in Pharmaceutical, Nutritional and Cosmetic Products (Deadline: 23 September 2022)
- The Role of Bioactive Natural Compounds in the Treatment of Diseases (Deadline: 30 September 2022)
- Exploiting the Biochemical Properties of Essential Oils for Healthy Products (Deadline: 18 October 2022)
- The Physiology and Pharmacology of Dopamine Receptors: From Normal Signaling to Pathology (Deadline: 28 October 2022)
- Development of Anticancer and Antiviral Drugs (Deadline: 4 November 2022)
- Targeted Delivery in Photodynamic Therapy (PDT) (Deadline: 20 November 2022)
- Peptide‐Based Radiopharmaceuticals for Tumors (Deadline: 25 November 2022)
- Toxicity Mechanisms and Toxicokinetics of Exogenous Toxic Substances (Deadline: 25 November 2022)
- New Insights into Marine Drugs Discovery (Deadline: 12 December 2022)
- The Latest Progress in Thrombosis and Antithrombotics (Deadline: 20 December 2022)
- Natural and Synthetic Drug Biological Activity in Modulating Immune System (Deadline: 23 December 2022)
- The Extracellular Matrix in Cancer Development: Roles and Challenges (Deadline: 23 December 2022)
- Endocannabinoid System in Health and Disease (Deadline: 31 December 2022)
- Cancer Treatment and Drug Resistance (Deadline: 1 January 2023)
- Silver Nanoparticles Synthesis, Characterization, Biological Activities (Deadline: 10 January 2023)
- New Insights into Cannabidiol Pharmacology: Relevance for Therapeutics (Deadline: 20 January 2023)